Comparative Benchmarking
In the context of the broader market, ODTX competes directly with industry leaders such as IVA and AURA. With a market capitalization of $764.18M, it holds a significant position in the sector. When comparing efficiency, ODTX's gross margin of N/A stands against IVA's 100.00% and AURA's N/A. Such benchmarking helps identify whether Odyssey Therapeutics Inc is trading at a premium or discount relative to its financial performance.